BACKGROUND: Skeletal muscle wasting commonly occurs in patients with chronic obstructive pulmonary disease (COPD) and has been associated with the presence of systemic inflammation. This study investigated whether rehabilitative exercise training decreases the levels of systemic or local muscle inflammation or reverses the abnormalities associated with muscle deconditioning. METHODS:Fifteen patients with COPD (mean (SE) forced expiratory volume in 1 s 36 (4)% predicted) undertook high-intensity exercise training 3 days/week for 10 weeks. Before and after the training programme the concentration of tumour necrosis factor alpha (TNFalpha), interleukin-6 (IL-6) and C-reactive protein (CRP) in plasma was determined by ELISA, and vastus lateralis mRNA expression of TNFalpha, IL-6, total insulin-like growth factor-I (IGF-I) and its isoform mechanogrowth factor (MGF) and myogenic differentiation factor D (MyoD) were assessed by real-time PCR. Protein levels of TNFalpha, IGF-I and MyoD were measured by Western blotting. RESULTS: Rehabilitation improved peak exercise work rate by 10 (2%) (p = 0.004) and mean fibre cross-sectional area from 4061 (254) microm(2) to 4581 (241) microm(2) (p = 0.001). Plasma inflammatory mediators and vastus lateralis expression of TNFalpha and IL-6 were not significantly modified by training. In contrast, there was a significant increase in mRNA expression of IGF-I (by 67 (22)%; p = 0.044), MGF (by 67 (15)%; p = 0.002) and MyoD (by 116 (30)%; p = 0.001). The increase observed at the mRNA level was also seen at the protein level for IGF-I (by 72 (36)%; p = 0.046) and MyoD (by 67 (21)%; p = 0.012). CONCLUSIONS: Pulmonary rehabilitation can induce peripheral muscle adaptations and modifications in factors regulating skeletal muscle hypertrophy and regeneration without decreasing the levels of systemic or local muscle inflammation.
RCT Entities:
BACKGROUND: Skeletal muscle wasting commonly occurs in patients with chronic obstructive pulmonary disease (COPD) and has been associated with the presence of systemic inflammation. This study investigated whether rehabilitative exercise training decreases the levels of systemic or local muscle inflammation or reverses the abnormalities associated with muscle deconditioning. METHODS: Fifteen patients with COPD (mean (SE) forced expiratory volume in 1 s 36 (4)% predicted) undertook high-intensity exercise training 3 days/week for 10 weeks. Before and after the training programme the concentration of tumour necrosis factor alpha (TNFalpha), interleukin-6 (IL-6) and C-reactive protein (CRP) in plasma was determined by ELISA, and vastus lateralis mRNA expression of TNFalpha, IL-6, total insulin-like growth factor-I (IGF-I) and its isoform mechanogrowth factor (MGF) and myogenic differentiation factor D (MyoD) were assessed by real-time PCR. Protein levels of TNFalpha, IGF-I and MyoD were measured by Western blotting. RESULTS: Rehabilitation improved peak exercise work rate by 10 (2%) (p = 0.004) and mean fibre cross-sectional area from 4061 (254) microm(2) to 4581 (241) microm(2) (p = 0.001). Plasma inflammatory mediators and vastus lateralis expression of TNFalpha and IL-6 were not significantly modified by training. In contrast, there was a significant increase in mRNA expression of IGF-I (by 67 (22)%; p = 0.044), MGF (by 67 (15)%; p = 0.002) and MyoD (by 116 (30)%; p = 0.001). The increase observed at the mRNA level was also seen at the protein level for IGF-I (by 72 (36)%; p = 0.046) and MyoD (by 67 (21)%; p = 0.012). CONCLUSIONS: Pulmonary rehabilitation can induce peripheral muscle adaptations and modifications in factors regulating skeletal muscle hypertrophy and regeneration without decreasing the levels of systemic or local muscle inflammation.
Authors: R A Rabinovich; E Ardite; T Troosters; N Carbó; J Alonso; J M Gonzalez de Suso; J Vilaró; J A Barberà; M F Polo; J M Argilés; J C Fernandez-Checa; J Roca Journal: Am J Respir Crit Care Med Date: 2001-10-01 Impact factor: 21.405
Authors: Richard Debigaré; Karine Marquis; Claude H Côté; Roland R Tremblay; Annie Michaud; Pierre LeBlanc; François Maltais Journal: Chest Date: 2003-07 Impact factor: 9.410
Authors: R A Rabinovich; M Figueras; E Ardite; N Carbó; T Troosters; X Filella; J A Barberà; J C Fernandez-Checa; J M Argilés; J Roca Journal: Eur Respir J Date: 2003-05 Impact factor: 16.671
Authors: Suzanne R Broussard; Robert H McCusker; Jan E Novakofski; Klemen Strle; Wen Hong Shen; Rodney W Johnson; Gregory G Freund; Robert Dantzer; Keith W Kelley Journal: Endocrinology Date: 2003-07 Impact factor: 4.736
Authors: Nicolas Kahn; Lowie E G W Vanfleteren; Georgios Kaltsakas; Vasileios Andrianopoulos; Daniela Gompelmann; Corina de Jong; Felix J F Herth Journal: J Thorac Dis Date: 2018-09 Impact factor: 2.895
Authors: François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner Journal: Am J Respir Crit Care Med Date: 2014-05-01 Impact factor: 21.405
Authors: Robert C Kaplan; Ann-Kristin Petersen; Ming-Huei Chen; Alexander Teumer; Nicole L Glazer; Angela Döring; Carolyn S P Lam; Nele Friedrich; Anne Newman; Martina Müller; Qiong Yang; Georg Homuth; Anne Cappola; Norman Klopp; Holly Smith; Florian Ernst; Bruce M Psaty; H-Erich Wichmann; Douglas B Sawyer; Reiner Biffar; Jerome I Rotter; Christian Gieger; Lisa S Sullivan; Henry Völzke; Kenneth Rice; Ariadni Spyroglou; Heyo K Kroemer; Y-D Ida Chen; Jenny Manolopoulou; Matthias Nauck; Howard D Strickler; Mark O Goodarzi; Martin Reincke; Michael N Pollak; Martin Bidlingmaier; Ramachandran S Vasan; Henri Wallaschofski Journal: Hum Mol Genet Date: 2011-01-07 Impact factor: 6.150